Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.7M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
31.8M
-
Shares change
-
-771K
-
Total reported value, excl. options
-
$90.7M
-
Value change
-
-$2.74M
-
Put/Call ratio
-
1
-
Number of buys
-
59
-
Number of sells
-
-35
-
Price
-
$2.85
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2024
111 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q2 2024.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.8M shares
of 44.7M outstanding shares and own 71.21% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.84M shares), PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. (2.77M shares), Harvey Partners, LLC (2.56M shares), AMH Equity Ltd (2.2M shares), VANGUARD GROUP INC (2.12M shares), Granahan Investment Management, LLC (1.93M shares), DIMENSIONAL FUND ADVISORS LP (1.83M shares), 272 Capital LP (1.54M shares), ROYCE & ASSOCIATES LP (1.44M shares), and BOOTHBAY FUND MANAGEMENT, LLC (1.34M shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.